-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EJahbC766G+sK4eO9qWyUyXWzYLbgj97qWUPMFrUApaYybjN5sHRr6uL9LATkCBt
 CmVR1XwZjrb39x+ZXUecLg==

<SEC-DOCUMENT>0001157523-10-000163.txt : 20100114
<SEC-HEADER>0001157523-10-000163.hdr.sgml : 20100114
<ACCEPTANCE-DATETIME>20100114154034
ACCESSION NUMBER:		0001157523-10-000163
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20100114
FILED AS OF DATE:		20100114
DATE AS OF CHANGE:		20100114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Origin Agritech LTD
		CENTRAL INDEX KEY:			0001321851
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - CROPS [0100]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51576
		FILM NUMBER:		10527618

	BUSINESS ADDRESS:	
		STREET 1:		NO. 21 SHENG MING YUAN ROAD
		CITY:			CHANGPING DISTRICT BEIJING
		STATE:			F4
		ZIP:			102206
		BUSINESS PHONE:		858-847-9000

	MAIL ADDRESS:	
		STREET 1:		NO. 21 SHENG MING YUAN ROAD
		CITY:			CHANGPING DISTRICT BEIJING
		STATE:			F4
		ZIP:			102206
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6142929.htm
<DESCRIPTION>ORIGIN AGRITECH LIMITED 6-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2010 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">
      <font style="font-size: 18pt"><b>UNITED STATES</b></font><br><font style="font-size: 18pt"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><br><font style="font-size: 13pt"><b>WASHINGTON,
      D.C. 20549</b></font><br><br><font style="font-size: 18pt"><b>FORM 6-K</b></font><br><br><b>REPORT
      OF FOREIGN PRIVATE ISSUER</b><br><b>PURSUANT TO RULE 13a-16 OR 15d-16 OF</b><br><b>THE
      SECURITIES EXCHANGE ACT OF 1934 </b><br><br><b>FOR THE MONTH OF <font style="font-size: 10pt; font-family: Times New Roman">JANUARY
      2010</font></b><br><b>COMMISSION FILE NUMBER <u>000-51576 </u></b><br><br><font style="font-size: 18pt"><b>ORIGIN
      AGRITECH LIMITED</b></font><br>(Translation of registrant's name into
      English)<br><br><b>No. 21 Sheng Ming Yuan Road, Changping District,
      Beijing 102206</b><br>(Address of principal executive office)
    </p>
    <p>
      Indicate by check mark whether the registrant files or will file annual
      reports under cover of Form 20-F or Form 40-F.
    </p>
    <p style="white-space: nowrap; text-align: center">
      <b>Form 20-F [X] &#160;&#160;&#160;&#160;&#160;&#160;Form 40-F [&#160;&#160;&#160;]</b>
    </p>
    <p style="white-space: nowrap">
      Indicate by check mark if the registrant is submitting the Form 6-K in
      paper as permitted by Regulation S-T Rule 101(b)(1):<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>
    </p>
    <p style="white-space: nowrap">
      Indicate by check mark if the registrant is submitting the Form 6-K in
      paper as permitted by Regulation S-T Rule 101(b)(7):<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>
    </p>
    <p>
      Indicate by check mark whether the registrant by furnishing the
      information contained in this Form is also thereby furnishing the
      information to the Commission pursuant to Rule 12g3-2(b) under the
      Securities Exchange Act of 1934.
    </p>
    <p style="white-space: nowrap; text-align: center">
      <b>Yes [&#160;&#160;&#160;] &#160;&#160;&#160;No [X]</b>
    </p>
    <p>
      If &quot;Yes&quot; is marked, indicate below the file number assigned to the
      registrant in connection with Rule 12g3-2(b): 82-________.
    </p>
    <div style="margin-right: 0pt; margin-left: 0pt; width: 100%; margin-bottom: 10pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <b>SIGNATURES </b>
    </p>
    <p>
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned, thereunto duly authorized.
    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td colspan="3" style="padding-left: 0.0px; text-align: center" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>ORIGIN AGRITECH LIMITED</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td style="width: 7%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 43%" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 7%" valign="top">
          By:
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 43%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>/s/ Liang Yuan</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 7%" valign="top">
          Name:
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 43%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Liang Yuan
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 7%" valign="top">
          Title:
        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 43%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Chief Executive Officer
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 50%">

        </td>
        <td style="width: 7%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 43%" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: left; width: 50%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Date: January 14, 2010
          </p>
        </td>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
      </tr>
    </table>
    </div>
    <div style="margin-right: 0pt; width: 100%; margin-left: 0pt; margin-bottom: 10pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">
      <b>EXHIBIT</b>
    </p>
    <div style="text-align:left">
    <table cellspacing="0" style="width: 100%; font-size: 10pt; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: left; width: 17%" valign="top">
          Exhibit Number
        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="border-bottom: solid black 1.0pt; padding-left: 0.0px; text-align: left; width: 82%" valign="top">
          Description
        </td>
      </tr>
      <tr>
        <td style="width: 17%">

        </td>
        <td style="width: 1%">

        </td>
        <td style="width: 82%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-left: 0.0px; text-align: right; padding-right: 0.0px; white-space: nowrap; width: 17%" valign="top">
          99.1
        </td>
        <td style="width: 1%">

        </td>
        <td style="padding-left: 0.0px; text-align: left; width: 82%" valign="top">
          Press release announcing the change in board members and Acting CFO.
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p style="text-align: left">

    </p>
    <p>

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a6142929ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2010 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 8pt; font-family: Times New Roman">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>Origin
      Agritech Limited Announces Change in Board of Directors and Acting Chief
      Financial Officer</b></font>
    </p>
    <p>
      BEIJING--(BUSINESS WIRE)--January 8, 2010--<b>Origin Agritech Limited
      (NASDAQ: SEED) (&#8220;Origin&#8221; or the &#8220;Company&#8221;)</b>,
      a leading technology-focused supplier of crop seeds in China, today
      announced that the company has approved of Dr. Yingqi Xia and Dr. James
      Kang as a members of the Board of Directors effective January 1, 2010.
      Dr. Yingqi Xia has been nominated for election to the Board of Directors
      of the Company to replace Mr. Steven Urbach, who has completed his
      contracted term as a director for the company. Dr. James Kang has been
      nominated for election to the Board of Directors of the Company to
      replace Mr. Dafang Huang, who has also completed his contracted term as
      a director for the company. The company is grateful for Steven and
      Dafang&#8217;s broad based experience and service to the company since 2005.
    </p>
    <p>
      Dr. Yingqi Xia will bring his considerable and relevant experience in
      the Company and within the Chinese economic development community. Dr.
      Xia sits as the Executive Deputy Director of Zhongguancun Science Park,
      the largest high-tech zone in China. Previous to his position as the
      Executive Deputy Director, Dr. Xia worked as the Division Chief for the
      World Bank Department in the Ministry of Finance in the People&#8217;s
      Republic of China and in the Chinese Embassy to the United States. Prior
      to this, Dr. Xia received his PhD. degree from University of Ottawa,
      Canada. The Company is honored and excited to welcome a director with
      Dr. Xia&#8217;s stature and strong government relationships to the board.
    </p>
    <p>
      Dr. James Kang will bring his considerable and relevant experience in
      the Company and within the international biotech research community. Dr.
      Kang sits as the Professor and Distinguished University Scholar for the
      Departments of Medicine, and Pharmacology and Toxicology, for University
      of Louisville School of Medicine as well as the National Specialist
      Professor and Director for Regenerative Medicine Research Center in West
      China Hospital, Sichuan University in China. Dr. Kang has also served as
      President and CEO of InnoRem, Inc. and President of International
      Organization of Life Science and Biotechnology. Prior to this, Dr. Kang
      received his PhD. Degree from Iowa State University and was a post
      graduate at Cornell University Medical College in New York. The Company
      is honored and excited to welcome a director with Dr. Kang&#8217;s expertise
      in the biotechnology arena to the board.
    </p>
    <p>
      Additionally, Mr. Irving H. Kau has been appointed as Acting Chief
      Financial Officer from his Vice President of Finance position. Mr.
      Yasheng Yang, formerly Acting Chief Financial Officer and Vice Chairman
      of the Board will still remain as Vice Chairman of the Board of
      Directors and remain involved in the company. The company congratulates
      Mr. Kau on his exceptional service and noteworthy experience, and is
      honored to have him continue on as Acting Chief Financial Officer
      following over 3 years of consistent service within the company. Mr. Kau
      has extensive work experience working in both global public equity and
      global private equity in conjunction with Asia-Pacific based companies.
      During his work experience, he has worked on the buy-side, sell-side,
      and company side. Prior to his work as Vice President of Finance for
      Origin Agritech, Mr. Kau worked with Chardan Capital, Merriman Curhan
      Ford, and Strategic Growth Incorporated, where he firm took senior
      management positions in invested portfolio companies. He also completed
      course work at University of Southern California towards a PhD. in
      Business Strategy. With a background in both finance and genetics while
      publishing several peer reviewed academic papers, Mr. Kau received
      undergraduate degrees from Johns Hopkins University and a graduate
      degree from Rice University, where he received the Jones Partners
      Scholarship (merit-based) to attend. Mr. Kau is a member of MENSA and
      The Global Finance Leadership Team of The Global Leader Groups.
    </p>
    <p>
      <u><b>About Origin</b></u>
    </p>
    <p>
      Founded in 1997 and headquartered in Beijing, Origin Agritech Limited
      (NASDAQ GS: SEED) is China&#8217;s leading, vertically-integrated agricultural
      biotechnology company specializing in research, development and
      production to supply the growing populations of China. Origin develops,
      grows, processes, and markets high quality, hybrid crop seeds to farmers
      throughout China and parts of Southeast Asia via a network of
      approximately 3,800 first-level distributors and 65,000 second-level
      distributors and retailers, and possesses a pipeline of genetically
      modified seed products including glyphosate resistant corn and Bt Corn.
      The first genetically modified corn seed product for China, Phytase
      corn, was approved in November 2009 of which Origin possesses exclusive
      rights. For further information, please log on <u>www.originagritech.com</u>.
    </p>
    <p>
      <u><b>Forward Looking Statement</b></u>
    </p>
    <p>
      This release contains forward-looking statements. All forward-looking
      statements included in this release are based on information available
      to us on the date hereof. These statements involve known and unknown
      risks, uncertainties and other factors, which may cause our actual
      results to differ materially from those implied by the forward-looking
      statements. In some cases, you can identify forward-looking statements
      by terminology such as &quot;may,&quot; &quot;will,&quot; &quot;should,&quot; &quot;could,&quot; &quot;expects,&quot;
      &quot;plans,&quot; &quot;anticipates,&quot; &quot;believes,&quot; &quot;estimates,&quot; &quot;predicts,&quot;
      &quot;potential,&quot; &quot;targets,&quot; &quot;goals,&quot; &quot;projects,&quot; &quot;continue,&quot; or variations
      of such words, similar expressions, or the negative of these terms or
      other comparable terminology. Although we believe that the expectations
      reflected in the forward-looking statements are reasonable, we cannot
      guarantee future results, levels of activity, performance or
      achievements. Therefore, actual results may differ materially and
      adversely from those expressed in any forward-looking statements.
      Neither we nor any other person can assume responsibility for the
      accuracy and completeness of forward-looking statements. Important
      factors that may cause actual results to differ from expectations
      include, but are not limited to, those risk factors discussed in
      Origin's filings with the SEC including its annual report on Form 20-F
      filed with the SEC on March 23, 2009. We undertake no obligation to
      revise or update publicly any forward-looking statements for any reason.
    </p>
    <p>

    </p>
    <p>
      CONTACT:<br>Origin Agritech Limited<br>Irving H. Kau,
      +011-86-136-8108-0243 or +1-949-726-8101<br>Acting Chief Financial
      Officer<br><u>Irving.kau@originseed.com.cn</u>
    </p>
    <p>

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
